ATE123814T1 - Gentechnologische menschliche cholinesterasen. - Google Patents

Gentechnologische menschliche cholinesterasen.

Info

Publication number
ATE123814T1
ATE123814T1 AT90105274T AT90105274T ATE123814T1 AT E123814 T1 ATE123814 T1 AT E123814T1 AT 90105274 T AT90105274 T AT 90105274T AT 90105274 T AT90105274 T AT 90105274T AT E123814 T1 ATE123814 T1 AT E123814T1
Authority
AT
Austria
Prior art keywords
organophosphorous
human acetylcholinesterase
prevention
treatment
genetic human
Prior art date
Application number
AT90105274T
Other languages
English (en)
Inventor
Hermona Soreq
Haim Zakut
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE123814T1 publication Critical patent/ATE123814T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT90105274T 1989-03-21 1990-03-20 Gentechnologische menschliche cholinesterasen. ATE123814T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL8970389A IL89703A (en) 1989-03-21 1989-03-21 Polynucleotide encoding human acetylcholinesterase, vectors comprising said polynucleotide, cells transformed by said vectors, enzyme produced by said transformed cell, and uses thereof

Publications (1)

Publication Number Publication Date
ATE123814T1 true ATE123814T1 (de) 1995-06-15

Family

ID=11059811

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90105274T ATE123814T1 (de) 1989-03-21 1990-03-20 Gentechnologische menschliche cholinesterasen.

Country Status (7)

Country Link
US (1) US5595903A (de)
EP (1) EP0388906B1 (de)
JP (1) JPH03195496A (de)
AT (1) ATE123814T1 (de)
CA (1) CA2012720A1 (de)
DE (1) DE69020018T2 (de)
IL (1) IL89703A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248604A (en) * 1991-07-22 1993-09-28 Bio-Technology General Corp. Enzymatically active recombinant human acetylcholinesterase and hosts and vectors for expression thereof
US6025183A (en) * 1994-02-28 2000-02-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Transgenic animal assay system for anti-cholinesterase substances
US6326139B1 (en) * 1996-01-11 2001-12-04 Yissum Research Development Company Of Hebrew University Of Jerusalem Method of screening for genetic predisposition to anticholinesterase therapy
US6441388B1 (en) 1998-10-13 2002-08-27 Rio Grande Medical Technologies, Inc. Methods and apparatus for spectroscopic calibration model transfer
US7098037B2 (en) 1998-10-13 2006-08-29 Inlight Solutions, Inc. Accommodating subject and instrument variations in spectroscopic determinations
US6157041A (en) * 1998-10-13 2000-12-05 Rio Grande Medical Technologies, Inc. Methods and apparatus for tailoring spectroscopic calibration models
US6770799B2 (en) * 2000-03-17 2004-08-03 Thompson Boyce Plant Res Expression of recombinant human acetylcholinesterase in transgenic plants
IL161354A0 (en) * 2004-04-13 2004-09-27 Yissum Res Dev Co NOVEL AChE VARIANTS
WO2007040568A2 (en) 2004-12-01 2007-04-12 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State Univeristy Production and use of human butyrylcholinesterase
US20090220587A1 (en) * 2005-02-01 2009-09-03 United State Army Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands
US7741431B2 (en) * 2005-02-01 2010-06-22 The United States Of America As Represented By The Secretary Of The Army Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
CN102036687A (zh) * 2008-05-16 2011-04-27 尼克塔治疗公司 胆碱酯酶部分与聚合物的共轭物
JP2013526840A (ja) 2009-12-21 2013-06-27 ファーマシーネ，インコーポレイテッド 組み換えブチリルコリンエステラーゼおよびその切断型
US20130071394A1 (en) 2011-09-16 2013-03-21 John K. Troyer Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
PL240561B1 (pl) 2017-10-09 2022-05-02 Gdanski Univ Medyczny Wektory DNA zdolne do transformacji i integracji z chromosomem Leishmania tarentolae zawierające gen kodujący butyrylocholinoesterazę BChE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA84232B (en) * 1983-01-21 1984-11-28 Bio Response Inc Isolation and culture of mammalian cells secreting acetylcholinesterase and recovering of acetylcholinesterase therefrom
IL75553A (en) * 1985-06-18 1993-07-08 Yeda Res & Dev Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto
US5248604A (en) * 1991-07-22 1993-09-28 Bio-Technology General Corp. Enzymatically active recombinant human acetylcholinesterase and hosts and vectors for expression thereof

Also Published As

Publication number Publication date
IL89703A0 (en) 1989-09-28
DE69020018T2 (de) 1995-10-26
US5595903A (en) 1997-01-21
EP0388906B1 (de) 1995-06-14
IL89703A (en) 2001-10-31
EP0388906A2 (de) 1990-09-26
CA2012720A1 (en) 1990-09-21
JPH03195496A (ja) 1991-08-27
EP0388906A3 (de) 1991-04-17
DE69020018D1 (de) 1995-07-20

Similar Documents

Publication Publication Date Title
ATE123814T1 (de) Gentechnologische menschliche cholinesterasen.
DE69940888D1 (de) Copolymer-1-verwandte polypeptide für die verwendung als molekulargewichtsmarker und zur therapie
SE8501050D0 (sv) Biologically active fragments of human antihemophilic factor and method for preparation thereof
ATE358176T1 (de) Menschliche dnase
DE68920223D1 (de) Enzymelektroden und ihre Herstellung.
ATE151111T1 (de) Rekombinante dns-verfahren und dadurch hergestellte produkte
ATE123060T1 (de) Tgf-beta induziertes gen und protein.
NZ332634A (en) Isolated autophosphorylating polypeptide having phosphoinositide-3-kinase activity
FI880845A0 (fi) bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
ATE208208T1 (de) Halogenid-enthaltende insulinzubereitungen
PT1318198E (pt) Processo para produzir um polipeptido recombinante que envolve a adicao de um inibidor de quimotripsina ao meio de cultura celular
FR2587340B1 (fr) Nouvelles tetraalkylpiperidines, leur preparation et leur utilisation comme stabilisants des matieres polymeres
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
FI885807L (fi) Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
FI91256C (fi) Menetelmä uusien terapeuttisesti aktiivisten bentsotiofeenien valmistamiseksi
DK381189D0 (da) N-2,3-butadienyl-tri- og -tetraaminoalkanderivater og deres anvendelse
EP1281763A3 (de) Early growth response-1 (EGR-1) transkriptions-faktor
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
DE60239670D1 (de) Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis
ATE90354T1 (de) Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden.
ATE80912T1 (de) Menschliche proteine des chinolinesterase-typs und ihre herstellung.
DK52685A (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
DK255190A (da) Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties